Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Debt Ratio (2017 - 2025)

Serina Therapeutics (SER) has disclosed Debt Ratio for 9 consecutive years, with 0.23 as the latest value for Q3 2025.

  • Quarterly Debt Ratio fell 84.49% to 0.23 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.23 through Sep 2025, down 84.49% year-over-year, with the annual reading at 5.59 for FY2022, 33.6% up from the prior year.
  • Debt Ratio hit 0.23 in Q3 2025 for Serina Therapeutics, down from 1.5 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 7.79 in Q3 2022 to a low of 0.18 in Q3 2023.
  • Historically, Debt Ratio has averaged 3.1 across 5 years, with a median of 2.69 in 2023.
  • Biggest five-year swings in Debt Ratio: plummeted 97.67% in 2023 and later surged 725.56% in 2024.
  • Year by year, Debt Ratio stood at 4.19 in 2021, then soared by 33.6% to 5.59 in 2022, then plummeted by 96.75% to 0.18 in 2023, then surged by 725.56% to 1.5 in 2024, then plummeted by 84.49% to 0.23 in 2025.
  • Business Quant data shows Debt Ratio for SER at 0.23 in Q3 2025, 1.5 in Q3 2024, and 1.04 in Q2 2024.